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Summary
Spongiform encephalopathies are believed to be trans-
mitted by self-perpetuating conformational conversion
of the prion protein. It was shown recently that funda-
mental aspects of mammalian prion propagation can
be reproduced in vitro in a seeded fibrillization of the
recombinant prion protein variant Y145Stop (PrP23–
144). Here we demonstrate that PrP23–144 amyloids
from different species adopt distinct secondary struc-
tures and morphologies, and that these structural dif-
ferences are controlled by one or two residues in a
critical region. These sequence-specific structural char-
acteristics correlate strictly with the seeding speci-
ficity of amyloid fibrils. However, cross-seeding of
PrP23–144 from one species with preformed fibrils
from another species may overcome natural sequence-
based structural preferences, resulting in a new amy-
loid strain that inherits the secondary structure and
morphology of the template. These data provide di-
rect biophysical evidence that protein conformations
are transmitted in PrP amyloid strains, establishing a
foundation for a structural basis of mammalian prion
transmission barriers.
Introduction
The prion diseases, or transmissible spongiform en-
cephalopathies (TSEs), are a group of fatal neurode-
generative disorders of mammals. Pathogenesis in
these unusual diseases is associated with a conforma-
tional rearrangement of the cellular prion protein (PrPC)
to an abnormal “scrapie” conformer, PrPSc (Aguzzi and
Polymenidou, 2004; Collinge, 2001; Prusiner, 1998; Weiss-
mann, 2004). While the benign PrPC conformer is mo-
nomeric and rich in α-helical structure, PrPSc is charac-
terized by an increased proportion of β structure, partial
resistance to proteolysis, and a propensity to aggregate
into amyloid fibrils and/or plaques. Although the pre-
cise nature of the pathogenic TSE agent remains con-
troversial, a growing body of evidence supports the
protein-only hypothesis, according to which PrPSc itself
is the infectious prion pathogen (Prusiner, 1982; Prusi-
ner, 1998). PrPSc is believed to self-perpetuate by a
unique mechanism involving binding to PrPC and in-
ducing a conversion of the latter protein to the PrPSc
state. Despite recent progress in understanding TSE
pathogenesis, two features of the disease remain espe-
cially puzzling. The first is the existence of multiple TSE
phenotypes (prion “strains”) within the same mamma-*Correspondence: witold.surewicz@case.edulian species, and the second is the presence of barriers
that control transmission of the disease between dif-
ferent species (Bruce and Fraser, 1991; Collinge, 2001).
Barriers in TSE transmissibility have emerged as a ma-
jor public health issue following recent epidemics of
bovine spongiform encephalopathy (BSE) and indi-
cations that BSE might have crossed the species bar-
rier to cause variant Creutzfeldt-Jakob disease (CJD) in
humans (Collinge, 1999; Prusiner, 1998). Furthermore,
there is a growing concern that the prion agent respon-
sible for chronic wasting disease spreading among elk
and deer could cross the species barrier to range cat-
tle, eventually posing a threat to humans (Miller and
Williams, 2004).
Much insight into the molecular basis of species bar-
riers and prion strain diversity has come from recent
studies of prion-based inheritance in yeast and fungi
(Chien and Weissman, 2001; Chien et al., 2003; Chien
et al., 2004; Chernoff, 2004; Derkatch et al., 1996; King
and Diaz-Avalos, 2004; Tanaka et al., 2004; Uptain and
Lindquist, 2002; Wickner et al., 2000). Progress in un-
derstanding molecular mechanisms of mammalian
prion propagation has been significantly slower, in part
due to difficulties in efficiently propagating the PrPC to
PrPSc conversion in vitro. Many aspects of species-
and strain-dependent barriers in TSE transmissibility
could be reproduced in cell-free conversion experi-
ments of Caughey and coworkers (Bessen et al., 1995;
Caughey, 2001; Kocisko et al., 1995; Raymond et al.,
1997). However, the limitation of these classical studies
was that the yields of the conversion were relatively low
and insufficient to sustain continuous propagation of
the prion state.
Recently we have shown that fundamental aspects
of mammalian prion propagation, including the species
barrier and strain variation, can be reproduced in vitro
in a highly efficient seeded fibrillization of a disease-
associated prion protein variant Y145Stop (PrP23–144)
(Vanik et al., 2004). This study, performed with purified
recombinant PrP23–144 of human, mouse, and Syrian
hamster, revealed that there is very strong amino acid
sequence specificity in cross-seeding of protein from
different species. Remarkably, substitution of a single
amino acid in a critical region encompassing residues
138 and 139 (Figure 1A) is sufficient to transform the
properties of these proteins to those of PrP23–144 from
another species. This study also demonstrated that se-
quence-based seeding barriers between proteins of
species A and B can be readily bypassed, and new bar-
riers established, by an adaptation process that in-
volves preseeding of protein A with fibrils of protein
from another species, leading to the emergence of a
new strain of fibrils A. The sequence and strain-depen-
dent seeding specificities of PrP23–144 fibrils as estab-
lished in our previous study are summarized in Figure
1B. Building on these initial observations, we here pro-
vide long-sought direct biophysical evidence that spe-
cies- and strain-dependent seeding specificities of
mammalian prion amyloids are fully encoded in distinct
fibril conformations, and that cross-species seeding
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64Figure 1. Species-, Mutation-, and Strain-
Dependent Seeding Specificities of PrP23–
144 Amyloid Fibrils
(A) Amino acid sequence comparison of hu-
man (hu), mouse (mo), and Syrian hamster
(Sha) PrP, highlighting amino acid differ-
ences in the 23–144 region.
(B) The pattern of seeding specificities for
PrP23–144 variants as determined in our pre-
vious study (Vanik et al., 2004). Formation of
amyloid by PrP23–144 is characterized by
nucleation-dependent kinetics, in which the
growth of amyloid is preceded by a lengthy
lag phase (Kundu et al., 2003; Vanik et al.,
2004). If preformed aggregate is added to
soluble protein monomer, this lag phase is
eliminated, indicating that the polymer has
seeded conversion of the soluble protein.
The capability of preformed amyloid (square
brackets) to seed conversion of a given solu-
ble PrP23–144 is represented by + (amyloid
seeds conversion) or − (amyloid lacks seed-
ing activity for this soluble protein). hu, mo, and Sha denote human, mouse, and Syrian hamster proteins, respectively; hu138 and hu138/139
denote I138M and I138M/I139M mutants of huPrP23–144, respectively, and Sha138/139 represents M138I/M139I variant of ShaPrP23–144.
[mo]Sha denotes “second-generation” amyloid fibrils of moPrP23–144 obtained by seeding moPrP23–144 with preformed amyloid of
ShaPrP23–144. [hu138]hu138/139 denotes second-generation amyloid fibrils of I138M huPrP23–144 obtained by seeding I138M huPrP23–144
with preformed amyloid of I138M/I139M huPrP23–144. N/D, not determined. To guide the reader, the last column of the table summarizes the
conclusions of the previous study, indicating the “equivalence” (in terms of seeding specificity) of mutant proteins or second-generation
fibrils to proteins from another species.may overcome natural sequence-based structural pref- r
aerences, leading to the emergence of new prion amy-
loid strains that adopt the conformational characteris- r
dtics of the seed.
l
nResults
f
sPrP23–144 Amyloid Conformation Correlates
awith Species-Dependent Seeding Specificity
bAs demonstrated in our previous study with human
g(hu), mouse (mo), and Syrian hamster (Sha) PrP23–144
f(Vanik et al., 2004), human and mouse protein fibrils
sshare identical seeding characteristics. Preformed fi-
tbrils of each of these two proteins can seed conforma-
vtional conversion of the other protein, but neither can
cseed the conversion of ShaPrP23–144. In contrast, Syr-
sian hamster PrP23–144 displays a different seeding
nspecificity: it can seed the conversion of moPrP23–144,
dbut not that of huPrP23–144 (see Figure 1B). The pat-
ttern of seeding barriers established in this study pro-
bvided us with a unique opportunity to directly address
ca fundamentally important question: do species-depen-
tdent seeding specificities of prion protein fibrils corre-
rlate with distinct fibril conformations? Here we have ap-
(proached this problem using Fourier transform infrared
a(FTIR) spectroscopy and atomic force microscopy
v(AFM).
rFTIR spectroscopy provides information about pro-
Ptein secondary structure. This method is particularly
dwell suited for studying amyloid fibrils since the amide
I mode in infrared spectra is especially sensitive to β
lsheet structures. The positions of infrared bands asso-
Aciated with these structures depend on many factors,
pincluding the strength of hydrogen bonds and molecu-
tlar packing of β strands (Surewicz and Mantsch, 1988;
Zandomeneghi et al., 2004). The spectra in the amide I megion for the freshly dissolved monomeric PrP23–144
re identical for all three species. Even upon band nar-
owing by Fourier self-deconvolution, these spectra are
ominated by a single band at 1648 cm−1, indicating a
argely unordered structure (Kundu et al., 2003 and data
ot shown). This is consistent with NMR data for the
ull-length PrP showing that, apart from the short β
trand 128–131, the entire 23–144 region is devoid of
ny α helices or β sheets (Zahn et al., 2000). After incu-
ation at room temperature, the PrP23–144 solution
radually converts to a viscous gel containing amyloid
ibrils (Figure 2). These fibril suspensions display FTIR
ignatures characteristic of β sheet structure. However,
he position and relative intensity of the β sheet bands
aries markedly between proteins from different spe-
ies (Figures 3A–3C). Human and mouse PrP23–144
how very similar spectra, with major amide I compo-
ent bands at 1628, 1639, and 1649 cm−1 and a shoul-
er at 1664 cm−1. While the first band is highly charac-
eristic of β sheet structure, the assignment of the 1639
and is less unambiguous as it may contain unresolved
ontributions from β sheets and a random conforma-
ion. Bands at 1649 and 1664 cm−1 are believed to rep-
esent an unordered structure and turns, respectively
Surewicz and Mantsch, 1988). In contrast to human
nd mouse proteins, ShaPrP23–144 displays only one
ery strong β sheet band at 1625 cm−1, with a broad
andom coil band centered at about 1648 cm−1. Thus,
rP23–144 amyloid fibrils display species-dependent
ifferences in the secondary structure.
Species-specific characteristics of PrP23–144 amy-
oids were further probed by atomic force microscopy.
fter incubation for periods of time longer than the lag
hase of the conversion, AFM images for all three pro-
eins showed an extensive network of amyloid fibrils. In
ost preparations these fibrils were very long, usually
Conformational Basis of Prion Transmission Barriers
65Figure 2. PrP23–144 Amyloid Fibrils as Visualized by Atomic Force
Microscopy
Fibrils shown in this AFM height image were formed upon incuba-
tion of ShaPrP23–144 in 50 mM phosphate buffer (pH 6.4) at a 400
M protein concentration. The scale bar corresponds to 500 nm. A
similar network of fibrils was seen in low-magnification AFM
images of other PrP23–144 variants studied, although high-magni-
fication images revealed species-dependent differences in fibril
morphology (see Figure 4).cies-dependent differences in the seeding specificity.a common architecture. Fibrils of human and mouse
Figure 3. Species- and Mutation-Dependent
Differences in the Secondary Structure of
PrP23–144 Amyloids as Revealed by FTIR
Spectroscopy
(A–C) FTIR spectra in a conformation-sensi-
tive amide I region of amyloid fibrils formed
spontaneously (no seeds) by PrP23–144 cor-
responding to different species. (A) huPrP23–
144 (hu), (B) moPrP23–144 (mo), (C) ShaPrP23–
144 (Sha).
(D–F) FTIR spectra of spontaneously formed
fibrils for species-mimetic variants of PrP23–
144. (D) M138I-M139I ShaPrP23–144 (Sha138/
139), (E) I138M huPrP23–144 (hu138), (F)
I138M/I139M huPrP23–144 (hu138/139). All
spectra were Fourier self-deconvolved using
identical parameters as described in Experi-
mental Procedures.extending beyond 5 m (Figure 2). However, high-mag-
nification images clearly reveal that PrP23–144 amy-
loids corresponding to different species do not all sharePrP23–144 (Figures 4A and 4B) always display marked
axial periodicity, with a mean peak-to-peak repeat dis-
tance of about 30 nm. Unlike amyloids formed by some
other proteins, these fibrils do not appear to be helical
or “rope-like” in morphology; rather, the axial repeats
seem to be of a segmented, “bead-like” nature similar
to that observed by AFM for fibrils of the yeast prion
protein Sup35 (Serio et al., 2000). In contrast to huPrP23–
144 and moPrP23–144, the vast majority of oligomeric
structures formed by ShaPrP23–144 appear as “smooth”
fibrils, with no detectable axial periodicity (Figure 4C).
Occasionally a second type of morphology was ob-
served in preparations of ShaPrP23–144 fibrils (Figure
4G). The latter fibrils had an apparent left-handed heli-
cal twist with an axial repeat distance of approximately
50 nm. Under the experimental conditions used, the lat-
ter fibril morphology was never observed for human or
mouse PrP23–144 and accounted for approximately
10% of all fibrils in AFM images of ShaPrP23–144.
The differences in nanoscale structure between seg-
mented and smooth amyloids were further confirmed
by longitudinal section analysis of AFM data in a height
mode (Figure 5). Plots of height along the axis of
huPrP23–144 and moPrP23–144 fibrils reveal very clear
and regular variations, with a mean repeat of about 30
nm. In contrast, sectioning through smooth ShaPrP23–
144 fibrils reveals only small and highly irregular varia-
tions in height, comparable to those seen in the back-
ground. Altogether, FTIR spectroscopy and AFM clearly
demonstrate differences in the conformation of amyloid
fibrils spontaneously formed by PrP23–144 corre-
sponding to different species. Importantly, these con-
formational characteristics strongly correlate with spe-
Cell
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Figure 4. Species- and Mutation-Dependent Differences in PrP23– 1
144 Fibril Morphology as Revealed by Atomic Force Microscopy
c
(A–F) AFM amplitude-mode images of typical amyloid fibrils formed o
spontaneously (no seeds) by (A) huPrP23–144, (B) moPrP23–144,
s(C) ShaPrP23–144, (D) M138I/M139I ShaPrP23–144, (E) I138M
ShuPrP23–144, and (F) I138M/I139M huPrP23–144.
(G and H) Images of a “helical” amyloid fibril of ShaPrP23–144 (G) h
and I138M/I139M huPrP23–144 (H). Fibrils with helical morphology M
were only observed for these two PrP23–144 variants and ac- a
counted for a minor fraction (w10%) of all fibrils in a given sample. h
Scale bar applies to all panels and corresponds to 100 nm. To
tguide the reader, panels are also labeled using the notation de-
oscribed in the legend to Figure 3.
t
m
gWhile human and Syrian hamster PrP23–144—a pair for
cwhich a strong seeding barrier exists—form structurally
idistinct amyloid fibrils, conformational properties of
s“seeding-compatible” huPrP23–144 and moPrP23–144
amyloids appear to be identical.
A
PMutational Control of PrP23–144 Amyloid
Conformation and Seeding Specificity H
dTo further probe the relationship between the seeding
specificity and structural properties of PrP23–144 amy- w
oloid fibrils, we took advantage of our observation that
cross-seeding properties of PrP23–144 fibrils can be o
smanipulated by “species-mimicking” point mutations
at positions 138 and 139 (Vanik et al., 2004). In human 1
dprion protein both positions are occupied by Ile, whereas
in mouse PrP Ile138 is replaced by Met, and in Sha s
sprotein Met is present at both positions 138 and 139
(Figure 1A). As shown previously (Vanik et al., 2004 and H
mFigure 1B), the I138M mutant of huPrP23–144 behaves
like moPrP23–144, and the I138M/I139M huPrP23– f
[144 variant mimics the seeding specificity of the ham-
ster protein. Conversely, the M138I/M139I mutant of m
zShaPrP23–144 can no longer seed the conversion of
hamster protein but adopts the seeding specificity m
aof huPrP23–144. To test whether these mutation-depen-
dent seeding characteristics correlate with conforma- sional characteristics of amyloid fibrils, we have again
sed FTIR spectroscopy and AFM. Remarkably, I138M/
139M huPrP23–144 amyloid, which acquired the seed-
ng properties of ShaPrP23–144, shows the FTIR
pectrum that is no longer characteristic of human pro-
ein but appears identical to that of ShaPrP23–144, with
single β sheet band at 1625 cm−1 (Figure 3F). A similar
henomenon was observed for the “humanized” vari-
nt of hamster protein, M138I/M139I ShaPrP23–144,
he FTIR spectrum of which changed to the one of an
uthentic human protein (cf. Figures 3A and 3D). There-
ore, species-specific mutations that change the seed-
ng specificity of PrP23–144 also alter the conformation
f the amyloid, with mutant protein fibrils adopting the
econdary structure of PrP corresponding to different
pecies. Consistent with this picture, the FTIR
pectrum of the I138M huPrP23–144 variant, which is
ndistinguishable in its seeding properties from human
nd mouse proteins, is essentially identical to that of
uPrP23–144 and moPrP23–144 (Figure 3). A strong
orrelation between mutation-dependent PrP23–144
eeding specificity and fibril conformation was further
orroborated by atomic force microscopy (Figures 4D–
F). Consistent with FTIR data, I138M/I139M huPrP23–
44 fibrils no longer displayed segmented morphology
haracteristic of human protein, with the vast majority
f these fibrils appearing as smooth structures very
imilar to those found for ShaPrP23–144. Analogous to
haPrP23–144, a minor population of I138M/I139M
uPrP23–144 amyloids appeared as helical fibrils.
138I/M139I ShaPrP23–144, on the other hand, formed
myloid structures lacking the smooth character of
amster protein fibrils and adopted morphological fea-
ures of huPrP23–144 fibrils. Finally, as expected based
n FTIR data, the I138M mutation alone did not affect
he morphology of huPrP23–144 fibrils. Thus, species-
imicking point mutations in a critical PrP23–144 re-
ion cause amyloid fibrils to adopt the conformation
haracteristic of protein from another species, account-
ng for mutation-dependent changes in the seeding
pecificity.
myloid Conformation Differentiates
rP23–144 Strains
aving established that amino acid sequence-depen-
ent seeding specificity of PrP23–144 correlates strictly
ith fibril conformation, we next addressed the issue
f the molecular basis of prion strain diversity. As dem-
nstrated previously (Vanik et al., 2004), fibrils formed
pontaneously by mouse and Syrian hamster PrP23–
44 have different seeding specificities: the former ones,
enoted [mo], seed human protein but fail to seed ham-
ter protein, whereas the latter ones, denoted [Sha],
eed moPrP23–144 but cannot seed huPrP23–144.
owever, moPrP23–144 fibrils obtained by preseeding
ouse protein with [Sha] have reversed seeding speci-
icity: these “second-generation” moPrP23–144 fibrils,
mo]Sha, have lost the ability to seed fibrillization of hu-
an protein and have gained the ability to seed fibrilli-
ation of hamster PrP23–144. Thus, preseeding of
ouse protein with [Sha] resulted in the emergence of
new strain of moPrP23–144 fibrils. Although this new
train has the primary sequence of mouse protein, it
Conformational Basis of Prion Transmission Barriers
67Figure 5. AFM Height Images Reveal Quanti-
tative Morphological Differences between
Periodic and Smooth PrP23–144 Amyloid Fi-
brils
(A) AFM height image of huPrP23–144 fibril
(top panel) and a plot of sample height along
the line between points X and Y (bottom
panel). This plot reveals an axial periodicity
with a mean peak-to-peak repeat distance of
30 nm. Deterioration of periodicity near the
end of the fibril is due to the presence of an
additional spherical oligomeric particle (sim-
ilar particles are found scattered in most
preparations of hu and moPrP23–144).
(B) AFM height image of moPrP23–144 fibril
(top panel) and height plot along the line be-
tween points X and Y (bottom panel), reveal-
ing a mean peak-to-peak axial period of 30
nm as for hu fibrils.
(C) AFM height image of ShaPrP23–144 fibril
(top panel) and height plot along the line be-
tween points X and Y (bottom panel). No ax-
ial periodicity was found for this fibril (irregu-
lar height variations observed in the plot are
comparable to those in the background).
Scale bar represents 100 nm (applies to all
panels).has acquired the seeding specificity of [Sha]. An analo-
gous phenomenon of seed-induced “strain adaptation”
was also observed for species-mimetic mutants of
huPrP23–144 (see Figure 1B). The key question we ad-
dress in the present study is, what is the conformational
basis of this strain-dependent seeding specificity?
As shown in Figure 3B, the FTIR spectrum of sponta-
neously formed fibrils of moPrP23–144 is characterized
by a β sheet band at 1628 cm−1 and another band at
1639 cm−1. As expected, an identical spectrum was
observed for second-generation moPrP23–144 fibrils,
[mo]mo, that were preseeded with [mo] (Figure 6A).
However, when moPrP23–144 was seeded with [Sha]
or hamster-mimetic I138M/I139M huPrP23–144 fibrils,
denoted [hu138/139], FTIR spectra of these second-
generation [mo]Sha or [mo]hu138/139 fibrils were quite dif-
ferent (Figures 6B and 6C). These spectra no longer had
characteristics of moPrP23–144 amyloid but appeared
very similar to those of ShaPrP23–144 and I138M/
I139M huPrP23–144 amyloid, with a single, strong β
sheet band at 1625 cm−1. A similar series of experi-
ments was performed with second-generation fibrils of
the mouse-mimetic protein I138M huPrP23–144. Also in
this case, the FTIR spectra of fibrils seeded with [Sha]
or [hu138/139] do not resemble those of self-seeded
I138M huPrP23–144 fibrils but, rather, are very similar
to the spectra of ShaPrP23–144 and I138M/I139M
huPrP23–144 fibrils (see Figures 6D–6F and 3E). These
spectral differences cannot result from the presence of
the seed, as this material accounts for only 2% (w/w)
of all protein in the sample and thus is essentially invisi-
ble in FTIR spectra. We therefore conclude that the newstrains of moPrP23–144 or I138M huPrP23–144 amyloid
fibrils, emerging as a result of cross-species seeding,
adopt the secondary structure of the parent seed.
Next we examined the morphological features of dif-
ferent strains of seeded moPrP23–144 fibrils. AFM micro-
graphs reveal that the morphology of second-genera-
tion [mo]mo fibrils is identical to that of spontaneously
formed moPrP23–144 fibrils, with a characteristic bead-
like structure and axial periodicity of about 30 nm.
However, when mouse protein was seeded with [Sha]
or hamster-mimetic [hu138/139], the resulting amyloid
fibrils appeared smooth and nonperiodic, exactly like
those of the Syrian hamster protein and completely dif-
ferent from those of spontaneously formed moPrP23–
144 fibrils (Figures 7A–7C and 4B). The inheritance of
morphological features of the seed was also observed
in cross-seeded fibrillization of mouse-mimetic I138M
huPrP23–144. Fibrils of this protein seeded with [Sha]
or hamster-mimetic [hu138/139] no longer had periodic
characteristics of self-seeded I138M huPrP23–144 fi-
brils but acquired the smooth morphology of the seed
(Figures 7D–7F). Altogether, the data clearly indicate
that formation of PrP23–144 amyloid by cross-species
seeding is accompanied by the acquisition of fibril ar-
chitecture from the parent amyloid template.
Discussion
Studies with conventional animals and transgenic mice
have established that the efficiency of TSE infectivity is
intimately linked to the degree of similarity between the
amino acid sequence of prion proteins in the donor and
Cell
68Figure 6. Cross-Seeded PrP23–144 Fibrils
Adopt the Secondary Structure of the Parent
Amyloid Seed
(A–C) FTIR spectra of second-generation
moPrP23–144 amyloid fibrils obtained by
seeding moPrP23–144 with preformed fibrils
of (A) moPrP23–144 ([mo]mo), (B) ShaPrP23–
144 ([mo]Sha), and (C) I138M/I139M huPrP23–
144 ([mo]hu138/139).
(D–F) FTIR spectra of I138M huPrP23–144
amyloid fibrils obtained by seeding I138M
huPrP23–144 with preformed fibrils of
(D) I138M huPrP23–144 ([hu138]hu138), (E)
ShaPrP23–144 ([hu138]Sha), and (F) I138M/
I139M huPrP23–144 ([hu138]hu138/139). Spec-
tra were Fourier self-deconvolved as de-
scribed in Experimental Procedures.acceptor of the infection (Prusiner et al., 1990; Scott et m
al., 2004). The critical role of PrP sequence similarity a
in cross-species transmissibility of the prion agent has s
been further corroborated by studies on scrapie- t
infected cell cultures (Priola and Chesebro, 1995; Priola f
et al., 2001) and in cell-free conversion assays (Caughey, s
2001; Kocisko et al., 1995; Raymond et al., 1997). How- a
ever, the molecular mechanism by which the prion pro- c
tein amino acid sequence controls these TSE species s
barriers remains enigmatic. The picture is further com- m
plicated by experimental evidence that multiple prion t
strains may exist within the same animal species (see o
below). d
s
sFibril Conformation Correlates
dwith Seeding Capability
bA wealth of data indicates that the propagation of pri-
tons in yeast and fungi occurs by a nucleation-
adependent (seeded) polymerization mechanism in which
uspontaneous formation of prion amyloid fibrils occurs
fonly after a characteristic lag phase, and this lag phase
gcan be eliminated upon addition of a small amount of
ppreformed fibrillar seeds (Glover et al., 1997; Serio et
sal., 2000). A similar mechanism has also been pos-
stulated for the propagation of mammalian prions, in
bwhich case PrPSc would act as an oligomeric seed
s(Caughey, 2001; Come et al., 1993). In support of this
mscenario, we have recently shown that the phenomena
areminiscent of species barriers and prion strain diver-
csity, as observed in animal studies, can be reproduced
min vitro in a seeded fibrillization of a purified prion pro-
ctein variant PrP23–144 (Vanik et al., 2004). This efficient
conversion system has provided us with a valuable aodel for studying mammalian prion species barriers
nd their molecular basis. The present study demon-
trates that there is a very strong correlation between
he seeding specificity of PrP23–144 fibrils from dif-
erent species and amyloid fibril conformation as mea-
ured by FTIR spectroscopy and AFM. Thus, human
nd mouse PrP23–144 fibrils, which are mutually fully
ompatible with respect to their seeding capability,
how essentially identical secondary structure and fibril
orphology. Human and hamster PrP23–144 fibrils, on
he other hand, each of which is completely incapable
f seeding formation of the other, have unequivocally
ifferent secondary structure and fibril architecture. The
eeding compatibility observed for the hu-mo pair, and
trong cross-seeding barrier for the hu-Sha pair, occur
espite considerably smaller overall sequence similarity
etween human and mouse PrP23–144 as compared to
hat between human and Syrian hamster proteins (five
nd eight amino acid differences, respectively; see Fig-
re 1A). However, species-specific substitutions of as
ew as one or two amino acids in the critical amyloido-
enic determinant of PrP23–144 are sufficient to com-
letely change the properties of human or Syrian ham-
ter PrP23–144, with mutant proteins adopting seeding
pecificity of PrP23–144 from another species. Invaria-
ly, these mutation-induced changes in cross-seeding
pecificity fully correlate with corresponding species-
imicking changes in the conformation of PrP23–144
myloid fibrils. Thus, the present findings strongly indi-
ate that it is not sequence similarity per se that deter-
ines the capacity of prion protein fibrils from one spe-
ies to seed conformational conversion of protein from
nother species. Rather, it appears that PrP amino acid
Conformational Basis of Prion Transmission Barriers
69Figure 7. Cross-Seeded PrP23–144 Fibrils Adopt the Morphology
of the Parent Amyloid Seed
(A–C) AFM images of second-generation moPrP23–144 amyloid
fibrils obtained by seeding moPrP23–144 with preformed fibrils
of (A) moPrP23–144, (B) ShaPrP23–144, and (C) I138M/I139M
huPrP23–144.
(D–F) AFM images of second-generation I138M huPrP23–144 amy-
loid fibrils obtained by seeding I138M huPrP23–144 with preformed
fibrils of (D) I138M huPrP23–144, (E) ShaPrP23–144, and (F) I138M/
I139M huPrP23–144. All images were obtained in the amplitude
mode. The scale bar applies to all panels and represents 100 nm.
To guide the reader, panels are also labeled using the notation de-
scribed in the legend to Figure 6.sequence is important only insofar as it confers a pref-
erence for a particular fibril conformation.
Cross-Species Seeding: The Role
of Conformational Adaptability
While these considerations clearly point to amyloid fi-
bril conformation as a key determinant of seeding
specificity in prion protein conversion, another layer of
complexity is revealed by intriguing observations re-
garding cross-species seeding between mouse and
Syrian hamster PrP23–144. Despite considerable differ-
ences between the conformations of spontaneously
formed [mo] and [Sha] fibrils, preformed [Sha] amyloid
can seed conversion of moPrP23–144. The opposite,
however, is not true: [mo] fibrils are completely incapa-
ble of inducing fibrillization of soluble ShaPrP23–144.
The most plausible explanation for this behavior is that
the conformation of [Sha] fibrils is within the spectrum
of conformers allowed to moPrP23–144, even though
the structure formed during de novo fibrillization of the
latter protein is different. On the other hand, the confor-
mation most preferred (i.e., attained in a spontaneousfibrillization) by [mo] amyloid appears to be outside the
range of conformations accessible to ShaPrP23–144,
accounting for the inability of [mo] fibrils to seed the
conversion of Sha protein. In other words, cross-seed-
ing requires monomeric protein to be “adaptable” to
the conformation of the amyloid seed. As a result of
this adaptability, cross-seeding of PrP23–144 from spe-
cies A with amyloid fibrils from species B may over-
come natural sequence-based structural preferences,
resulting in a new strain of amyloid A which inherits
conformational traits of the template amyloid B. This
conformational adaptation results in an altered seeding
specificity, allowing the newly emerged strain to cross
transmissibility barriers that are impermeable to the
original strain formed by de novo fibrillization of the
same protein.
One of the most intriguing and least understood as-
pects of transmissible spongiform encephalopathies is
the existence of a wide variety of strains of the infec-
tious TSE agent, which gives rise to different disease
phenotypes within the same species (Bruce and Fraser,
1991; Collinge, 2001). Since the PrP gene in these ani-
mals is identical, prion strain diversity has for many
years presented a major challenge to the protein-only
hypothesis, fueling speculations regarding the exis-
tence of a nucleic acid genome in the infectious prion
agent (Weissmann, 2004). Only recently has experimen-
tal evidence started to emerge suggesting that multiple
prion strains can be accommodated within the frame-
work of the protein-only hypothesis, with individual
strains representing distinct conformations of PrPSc
(Bessen and Marsh, 1994; Caughey et al., 1998; Peretz
et al., 2002; Safar et al., 1998; Telling et al., 1996). The
present findings yield a strong support for this purely
conformational model. Although molecular chaperones
and other cellular cofactors may modulate prion infec-
tivity in vivo (Chernoff, 2004; Supattapone, 2004; Telling
et al., 1995), the ability to propagate different strains of
PrP amyloid using highly purified recombinant protein
clearly argues that, at the basic mechanistic level, prion
strains are a truly protein-only phenomenon resulting
from inherent conformational variability in amyloids.
The present biophysical evidence for conformational
correlates of PrP amyloid seeding specificity, together
with the emerging principle of conformational adapt-
ability, provides a unified explanation of prion strains
and species barriers in TSE transmission. Our data
strongly suggest that the infectivity is really a confor-
mational property of a particular prion (i.e., PrPSc) strain,
and that this conformation depends not so much on
PrP amino acid sequence as on the history of the strain.
Amino acid sequence, on the other hand, dictates the
spectrum of conformations that PrPC of the host can
adopt upon conversion to the PrPSc state; a transmis-
sion may occur only if this spectrum includes the con-
formation of the donor PrPSc strain. Thus, prion strains
and species barriers are essentially inseparable phe-
nomena, representing different sides of the same coin.
Implications
A conceptually similar conformational basis of trans-
missibility barriers has been inferred from studies using
Sup35, the determinant of the yeast prion state [PSI+]
Cell
70(Chien and Weissman, 2001; Chien et al., 2003; Chien m
et al., 2004). Although conformational correlates of s
seeding specificity established in this study for PrP23– i
144 amyloid are more well defined at the biophysical y
level, Sup35 amyloid has the important advantage of t
being infectious in vivo. Importantly, recent experi- t
ments with this experimentally more tractable system
Edemonstrated that conformationally distinct Sup35 am-
yloid strains formed in vitro faithfully transmit strain-
Especific prion phenotypes after introduction to cells
E
(King and Diaz-Avalos, 2004, Tanaka et al., 2004). The p
infectivity of PrP23–144 amyloid in vivo has not been 2
yet demonstrated, although limited infectivity has been 1
precently reported for amyloid fibrils formed by PrP90–
e231 fragment (Legname et al., 2004). Experiments sim-
filar to those reported in our present study have not yet
cbeen possible for PrP90–231 or the full-length protein
m
due to practical difficulties in propagating efficient p
seeded conversion of the latter proteins under physio- w
logically relevant buffer conditions (Baskakov, 2003; a
PLee and Eisenberg, 2003). Nonetheless, the striking
bsimilarity of the conclusions reached in the studies with
tSup35 and PrP23–144, even though these proteins lack
e
any sequence similarity and entirely different experi-
mental approaches were used, strongly suggests that P
the basic mechanistic principles established for PrP23– T
144 are of general validity and also apply to the full- b
Blength mammalian prion protein. In the latter case, how-
zever, the precise pattern of species-dependent barriers
6might be further modulated by residues beyond the 23–
c144 region of PrP (Caughey, 2001; Kocisko et al., 1995;
w
Priola et al., 2001; Scott et al., 2004). p
The present findings regarding the crucial role of fibril p
conformation in PrP amyloid seeding specificity can t
Texplain some of the most perplexing observations on
cTSE transmissibility in animals, including the strain-
(dependent differences in infectivity of Syrian hamster
w
scrapie to mice (Kimberlin and Walker, 1977; Kimberlin i
and Walker, 1978) and of human CJD to transgenic l
mice (Bruce et al., 1997; Hill et al., 1997; Scott et al., c
1999). Most importantly, our model explains at the mo-
lecular level how variant CJD might have arisen as a F
Fnew strain of human prion by conformational adapta-
Btion of human PrP to the structure of exogenous BSE
dprions (Bruce et al., 1997; Collinge, 2001; Hill et al.,
i
1997; Scott et al., 1999). The emerging picture that s
prion protein can be “forced” into any of several strains r
by cross-seeding with PrPSc from compatible donors b
braises the unsettling possibility that, in principle, prions
bcould cross essentially any species barriers by gradual
lconformational adaptation resulting from repeated
acrosstransmission events. This should be of particular
a
concern in light of recent epidemics of chronic wasting
disease among North American cervids (Miller and Wil- A
liams, 2004). A
Apart from their implications for understanding the m
molecular basis of TSE transmissibility, the present s
pfindings are also highly intriguing in the context of basic
mprinciples of protein science. From this perspective, the
cnext frontier is to determine whether conformational
a
differences between individual prion amyloid strains c
merely reflect differences in the packing of PrP mono- u
mers (this could possibly account for the observed dif- a
iferences in FTIR spectra) or if, rather, they representore profound differences at the level of protein tertiary
tructure. Answers to this question are of fundamental
mportance for understanding how the existence of am-
loid strains could be reconciled with the principle that
he amino acid sequence is the key determinant of pro-
ein fold (Anfinsen et al., 1961).
xperimental Procedures
xpression and Purification of PrP23–144 Variants
xpression vectors for His-tagged variants of huPrP23–144 were
repared as described previously (Morillas et al., 1999; Vanik et al.,
004). Plasmids for the expression of moPrP23–144 and ShaPrP23–
44 were provided by Dr. Robert Petersen. All proteins were ex-
ressed in E. coli and purified by nickel ion affinity chromatography
ssentially as described (Morillas et al., 1999), omitting glutathione
rom the refolding buffer. The N-terminal polyhistidine tag was
leaved using biotinylated thrombin (Novagen), followed by re-
oval of thrombin by capture on streptavidin-agarose beads. Free
olyhistidine tag was then removed by dialysis against ultrapure
ater. All proteins were stored as a lyophilized powder before use
nd had a final purity better than 95% as determined by SDS-
AGE. Molecular masses of the PrP23–144 variants were confirmed
y MALDI mass spectrometry. In all experiments, protein concen-
ration was measured from absorbance at 276 nm using a molar
xtinction coefficient of 42,150 M−1 cm−1 for all PrP23–144 variants.
reparation of PrP23–144 Amyloid Fibrils
he procedure for inducing amyloid formation by PrP23–144 has
een described previously (Kundu et al., 2003; Vanik et al., 2004).
riefly, lyophilized protein was dissolved in Milli-Q water and fibrilli-
ation was initiated by addition of potassium phosphate buffer (pH
.4) to a final buffer concentration of 50 mM. The final protein con-
entration was 400 M in all cases. Samples for FTIR spectroscopy
ere prepared in an identical fashion, except that D2O was used in
lace of water and buffer composition was adjusted to give a final
D of 6.4; the pH electrode reading was compensated for the iso-
ope effect. All samples contained a cocktail of protease inhibitors.
he formation of amyloid fibrils was confirmed by atomic force mi-
roscopy and/or thioflavine T fluorescence as described previously
Vanik et al., 2004). For seeding experiments, a small amount (2%
/w) of preformed fibrillar aggregates was added to soluble protein
mmediately after reconstitution in buffer. In order to break up very
arge aggregates, the fibrillar protein used for seeding was soni-
ated in a bath-type sonicator.
TIR Spectroscopy
ourier transform infrared spectroscopy was performed using a
ruker IFS66 spectrometer continuously purged with dry air. For
ata acquisition, protein samples were placed between two pol-
shed CaF2 discs separated by a 50 m PTFE spacer. A total of 256
cans was accumulated and averaged for each spectrum at 2 cm−1
esolution. Spectra were corrected for residual absorption of buffer
y interactively subtracting the spectrum of buffer alone until a flat
aseline was obtained between 1700 and 1850 cm−1. Overlapping
ands in the amide I region were resolved by Fourier self-deconvo-
ution (Surewicz and Mantsch, 1988) in the Opus 4.0 software pack-
ge, using a Lorentzian band shape and parameters equivalent to
15 cm−1 half-width and a resolution enhancement factor of 1.6.
tomic Force Microscopy
FM imaging was performed on a Digital Instruments MultiMode
icroscope equipped with a NanoScope IV controller and a type E
canner. Protein samples were prepared for imaging as described
reviously (Kundu et al., 2003). Imaging was performed in tapping
ode in air using single-beam silicon probes with a nominal spring
onstant of 40 N/m and nominal tip radius of 10 nm. Data were
cquired in both height and amplitude modes. All images were pro-
essed by interactive plane fitting and Gaussian low-pass filtering
sing the Nanoscope SPM software package. Average fibril height
nd axial periodicity were measured from processed AFM height
mages using Nanoscope offline analysis routines as previously de-
Conformational Basis of Prion Transmission Barriers
71scribed (Kad et al., 2003). There was no substantial difference be-
tween PrP23–144 fibrils formed in water and those formed in deu-
terated buffer.
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